This editorial is a follow-up to Redberg’s 2017 editorial: Statins for Primary Prevention: The debate is intense, but the data are weak. It examines the updated USPSTF recommendations on the use of statins for primary prevention. The authors note that … Continue reading →
Statins for Primary Cardiovascular Disease (CVD) Prevention: Time to Curb Our Enthusiasm A Habib, M Katz, R Redberg JAMA Internal Medicine published online 8/23/22.
This editorial is a follow-up to Redberg’s 2017 editorial: Statins for Primary Prevention: The debate is intense, but the data are weak. It examines the updated USPSTF recommendations on the use of statins for primary prevention. The authors note that … Continue reading →